Search research articles
Contact Us
Filters
Showing results (401-410 of 655) with videos related to
Page
of 66
Sort By:
The American Journal of Surgical Pathology
|
October 26, 2012
Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis
Maristela L Onozato, Alexandra E Kovach, Beow Y Yeap, et al.
Histopathology
|
December 14, 2020
Identification of EWSR1-NFATC2 fusion in simple bone cysts
Yin P Hung, Adam S Fisch, Julio A Diaz-Perez, et al.
JCO Precision Oncology
|
April 30, 2019
Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer-Transformed <i>EGFR</i> Mutant Non-Small-Cell Lung Cancer
Meghan J Mooradian, Zofia Piotrowska, Benjamin J Drapkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2018
Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer
Ibiayi Dagogo-Jack, Pablo Martinez, Beow Y Yeap, et al.
Clinical Trials (London, England)
|
September 17, 2015
Oversight on the borderline: Quality improvement and pragmatic research
Jonathan A Finkelstein, Andrew L Brickman, Alexander Capron, et al.
Urologia Internationalis
|
April 12, 2016
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up
Daniele D''Agostino, Marco Racioppi, Dario Pugliese, et al.
Cancer
|
June 19, 2013
Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation
Eunice L Kwak, Geoffrey I Shapiro, Seth M Cohen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 16, 2017
ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non-Small Cell Lung Cancer
Jessica J Lin, Lauren L Ritterhouse, Siraj M Ali, et al.
Cancer Research
|
June 20, 2017
The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in <i>IDH1</i>-Mutant Cancers and Potentiates NAD<sup>+</sup> Depletion-Mediated Cytotoxicity
Kensuke Tateishi, Fumi Higuchi, Julie J Miller, et al.
Nature Protocols
|
November 13, 2021
Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq
Nikolay L Malinin, GaHyun Lee, Cicera R Lazzarotto, et al.
Page
of 66
Search research articles
Search
Showing results (401-410 of 655) with videos related to
Sort By:
Page
of 66
The American Journal of Surgical Pathology
|
October 26, 2012
Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis
Maristela L Onozato, Alexandra E Kovach, Beow Y Yeap, et al.
Histopathology
|
December 14, 2020
Identification of EWSR1-NFATC2 fusion in simple bone cysts
Yin P Hung, Adam S Fisch, Julio A Diaz-Perez, et al.
JCO Precision Oncology
|
April 30, 2019
Clonal Evolution and the Role of Serial Liquid Biopsies in a Case of Small-Cell Lung Cancer-Transformed <i>EGFR</i> Mutant Non-Small-Cell Lung Cancer
Meghan J Mooradian, Zofia Piotrowska, Benjamin J Drapkin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 19, 2018
Impact of BRAF Mutation Class on Disease Characteristics and Clinical Outcomes in BRAF-mutant Lung Cancer
Ibiayi Dagogo-Jack, Pablo Martinez, Beow Y Yeap, et al.
Clinical Trials (London, England)
|
September 17, 2015
Oversight on the borderline: Quality improvement and pragmatic research
Jonathan A Finkelstein, Andrew L Brickman, Alexander Capron, et al.
Urologia Internationalis
|
April 12, 2016
Postoperative Quality of Life in Patients with Ileal Neobladder at Short-, Intermediate- and Long-Term Follow-Up
Daniele D''Agostino, Marco Racioppi, Dario Pugliese, et al.
Cancer
|
June 19, 2013
Phase 2 trial of afatinib, an ErbB family blocker, in solid tumors genetically screened for target activation
Eunice L Kwak, Geoffrey I Shapiro, Seth M Cohen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 16, 2017
ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non-Small Cell Lung Cancer
Jessica J Lin, Lauren L Ritterhouse, Siraj M Ali, et al.
Cancer Research
|
June 20, 2017
The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in <i>IDH1</i>-Mutant Cancers and Potentiates NAD<sup>+</sup> Depletion-Mediated Cytotoxicity
Kensuke Tateishi, Fumi Higuchi, Julie J Miller, et al.
Nature Protocols
|
November 13, 2021
Defining genome-wide CRISPR-Cas genome-editing nuclease activity with GUIDE-seq
Nikolay L Malinin, GaHyun Lee, Cicera R Lazzarotto, et al.
Page
of 66